Anika takes actions to strengthen liquidity in light of covid-19

Bedford, mass., april 08, 2020 (globe newswire) -- anika therapeutics, inc. (nasdaq: anik), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (“ha”) technology platform, today provided an update on actions it is taking to strengthen liquidity in light of the covid-19 pandemic.
ANIK Ratings Summary
ANIK Quant Ranking